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a b s t r a c t
Hepatitis C virus (HCV) replicates in membrane associated, highly ordered replication complexes (RCs).
These complexes include viral and host proteins necessary for viral RNA genome replication. The
interaction network among viral and host proteins underlying the formation of these RCs is yet to be
thoroughly characterized. Here, we investigated the association between NS4B and NS5A, two critical RC
components. We characterized the interaction between these proteins using ﬂuorescence resonance
energy transfer and a mammalian two-hybrid system. Speciﬁc tryptophan residues within the
C-terminal domain (CTD) of NS4B were shown to mediate this interaction. Domain I of NS5A, was
sufﬁcient to mediate its interaction with NS4B. Mutations in the NS4B CTD tryptophan residues
abolished viral replication. Moreover, one of these mutations also affected NS5A hyperphosphorylation.
These ﬁndings provide new insights into the importance of the NS4B–NS5A interaction and serve as a
starting point for studying the complex interactions between the replicase subunits.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Hepatitis C virus (HCV) infection affects millions worldwide
and is one of the leading causes of chronic liver disease. Prolonged
HCV infection may lead to liver cirrhosis and liver failure and is
associated with the development of liver cancer (El-Serag, 2011).
HCV is a positive strand RNA virus, that like other members of this
group, replicates in membrane associated replication complexes
(RC). These altered membranes are thought to be endoplasmic
reticulum (ER) derived and to contain in addition to the viral
genome and proteins, a variety of host factors necessary for viral
replication (Miller and Krijnse-Locker, 2008).
Once the positive strand RNA genome enters the host cell, its
single open reading frame is translated into a polyprotein. This
polyprotein is co- and post-translationally processed to yield three
structural proteins (core, E1 and E2), an ion-channel (p7), and six
non-structural proteins (NS2, NS3, NS4A, NS4B, NS5A, NS5B)
(Grakoui et al., 1993b). The minimal set of proteins essential for
viral replication consists of NS3, NS4A, NS4B, NS5A and NS5B
(Lohmann et al., 1999). Most of these proteins have known
activities: NS3 is a helicase and a serine protease that uses NS4A
as a cofactor. NS5B is the viral RNA-dependent RNA polymerase
(Ago et al., 1999; Bressanelli et al., 1999; Grakoui et al., 1993a;
Hijikata et al., 1993; Lesburg et al., 1999). The exact role of NS4B
and NS5A, which are essential for viral replication and have a role
in assembly, is still not fully understood.
NS4B is a 27 kDa, ER localized, small, hydrophobic transmem-
brane protein thought to induce the membranous web: modiﬁed
membrane elements that comprise the viral RC (Egger et al., 2002).
NS4B contains three major segments: a cytoplasmic N-terminal
part (a.a. 1 to 69), shown to contain two amphipathic helices
(AH1 and AH2) (Elazar et al., 2004; Gouttenoire et al., 2010); a
central domain that contains four putative transmembrane seg-
ments (a.a. 70 to 191) and a cytoplasmic C-terminal part (a.a.
191 to 261) that contains two conserved helices (H1 and H2)
(Gouttenoire et al., 2009; Jones et al., 2009; Lundin et al., 2003).
Three main features of NS4B are thought to contribute to its
activity in the induction of the membranous web formation: The
ﬁrst is its ability to form oligomers, mediated by several domains
of the protein, mainly AH2 and elements at the C-terminus
(Gouttenoire et al., 2010; Paul et al., 2011; Yu et al., 2006). The
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second feature is the ability NS4B's AH2 domain to promote lipid
vesicle aggregation (Cho et al., 2010). The third feature is the
ability NS4B's N-terminal domain to post-translationally translo-
cate from the cytosolic face of the ER into its lumen. NS5A was
found to negatively affect this translocation, suggesting that NS5A
inﬂuences the topology of NS4B (Lundin et al., 2006).
NS5A is a 56–58 kDa phosphorylated protein, occurring in
different phosphorylation states, the exact role of these different
phosphorylation states in the viral life cycle is still unclear. Adaptive
mutations reducing the amount of hyperphosphorylated NS5A
increase viral replication (Appel et al., 2005b; Blight et al., 2000;
Katze et al., 2000; Tanji et al., 1995b). Furthermore, inhibition of
NS5A hyperphosphorylation by kinase inhibitors yields similar
consequences (Neddermann et al., 2004). Yet, low levels of hyper-
phosphorylated NS5A seem to be essential for viral replication since
viral replication is inhibited upon its complete loss (Appel et al.,
2005a; Fridell et al., 2011). The increase in viral replication caused
by reduced levels of the NS5A hyperphosphorylated form inversely
correlates with viral production, leading to the notion that the
hyperphosphorylated form of NS5A has adverse effects on viral
replication but is required for viral assembly (Masaki et al., 2008;
Miyanari et al., 2007; Pietschmann et al., 2009; Tellinghuisen et al.,
2008a). It was also proposed to regulate the interface between
replication and assembly (Tellinghuisen et al., 2008a). Several non-
structural proteins including NS4B were found to facilitate NS5A
phosphorylation (Koch and Bartenschlager, 1999; Neddermann et
al., 1999). The N-terminal domain of NS5A contains an amphipathic
helix that mediates its membrane association (Elazar et al., 2003).
The rest of the protein is organized in three domains (I, II, and III),
which are separated by repetitive low-complexity sequences
(Tellinghuisen et al., 2004). Domain I has been attributed to the
replicase activity of NS5A (Tellinghuisen et al., 2005). Although a
large part of domain II could be deleted without effecting replica-
tion or production of the virus (Appel et al., 2008), deletion of a
speciﬁc region or deletion of the whole domain abolished viral
replication (Appel et al., 2008; Tellinghuisen et al., 2008b). In
contrast, domain III has been shown to be dispensable for RNA
replication (Appel et al., 2008; Tellinghuisen et al., 2008a). Muta-
tions and insertions in domain III showed impact on virus particle
assembly (Appel et al., 2008). Domain I was crystallized as a dimer,
leading to the notion that NS5A functions as a multimer (Love et al.,
2009; Tellinghuisen et al., 2005).
Traditionally, NS4B was thought to be the sole driving force for
the induction of the membrane alterations that harbor the RCs
(Egger et al., 2002). It was recently shown that double membrane
vesicles that appear in infected cells upon the initiation of viral
replication are induced by NS5A, highlighting a critical role for both
NS4B and NS5A in this initial step in the establishment of the viral
RC (Romero-Brey et al., 2012). A genetic interaction between NS4B
and NS5A was reported, where a mutation in the C-terminal
domain of NS4B that abolished viral replication was rescued by a
pseudoreversion in NS4B and an additional mutation in domain I of
NS5A (Paul et al., 2011). Similarly, replacement of the NS4B C-
terminal domain from a genotype 2a genome with sequences from
genotype 1b attenuated virus production. The phenotype was
rescued by two adaptive mutations one in the C-terminal of NS4B
and the other in NS5A domain III (Han et al., 2013).
NS4B and NS5A were previously shown to physically interact
(Aligo et al., 2009; Dimitrova et al., 2003; Gao et al., 2004),
however, in spite of their aforementioned functional association,
this interaction was never characterized, most likely due to the
hydrophobic nature of NS4B that complicates biochemical analy-
sis. Using immunoﬂuorescence, ﬂuorescence resonance energy
transfer (FRET) and a mammalian two-hybrid system approach,
we conﬁrmed this interaction. The C-terminal domain of NS4B and
domain I of NS5A, were found to contain the major determinants
that mediate the NS4B–NS5A interaction. Furthermore, mutations
in NS4B's C-terminal domain that affected this interaction abol-
ished viral replication. One of these mutations also inhibited NS5A
phosphorylation. These results may provide additional insights
into organization of the viral RC, towards an informed model of its
functional mechanism.
Results
NS4B and NS5A are both known to be essential components of
HCVs replicase machinery and as such are expected to colocalize
within RCs (Lohmann et al., 1999). As a baseline for our forthcoming
experiments, their localization in replicon cells was conﬁrmed. To
this end, Bart-HA cells (Huh7 cells harboring a subgenomic 1b
replicon with an HA tag insertion in NS5A) were used for immuno-
ﬂuorescence analysis with speciﬁc antibodies. Both proteins dis-
played a typical reticular ER and a speckle-like pattern, thought to
represent the membrane rearrangements harboring the viral RCs
(Egger et al., 2002; Ide et al., 1996; Polyak et al., 1999; Tanji et al.,
1995a). NS4B and NS5A colocalized in these structures (Fig. S1). NS4B
is a highly hydrophobic transmembrane protein, previous studies
reported unsuccessful attempts to study its interaction with NS5A
using immunoprecipitation of ectopically expressed proteins or from
infected cells (Blight, 2011; Han et al., 2013). Thus, we used an
experimental approach that allows analysis of proteins in their native
intact membranes namely, Fluorescence Resonance Energy Transfer
(FRET). FRET occurs between two ﬂuorophores with partially over-
lapping emission of one (the donor) and excitation of the other (the
acceptor) when the two molecules are very close to each other (less
then 10 nm). The efﬁciency of the FRET is inversely proportional to
the distance to the power of 6. Thus, FRET between two ﬂuorescently
tagged molecules is a strong indication for interaction (Kenworthy,
2001). In acceptor photobleaching, occurrence of FRET is detected as
the increase in the ﬂuorescence emission of the dequenched donor
ﬂuorophore following photobleaching of the acceptor. Here FRET was
carried out using repetitive partial acceptor photobleaching to
demonstrate a correlation between acceptor photobleaching and
donor ﬂuorescence increase (Fig. S2). Full length NS4B or NS5A from
HCV genotype 1b or 2a were each fused to GFP or mCherry that were
then used as a donor-acceptor pair for FRET analysis, following their
coexpression in Huh7 cells (Fig. 1A). GFP-tagged Pendrin (PDS) a
plasma membrane iodide transporter that upon overexpression is
essentially retained and accumulated in the ER (Shepshelovich et al.,
2005) was used as a negative control. NS4B (genotype 1b), previously
shown by FRET to oligomerize, was used as a positive control
(Gouttenoire et al., 2010). As expected, a signiﬁcant FRET signal
(mean EF 6.673.5, poPr0.03) was observed in cells coexpressing
GFP- and mCherry-tagged NS4B, while insigniﬁcant FRET was
detected in cells expressing PDS together with NS4B or NS5A. A
signiﬁcant FRET signal, comparable to the NS4B positive control, was
observed in cells coexpressing NS5A-GFP and NS4B-mCherry from
genotype 2a (mean EF 5.577.2, po0.001). A lower, yet noticeable
FRET signal was detected in cells coexpressing NS5A-mCherry and
NS4B-GFP from genotype 1b (mean EF 6.073.8). Chimeras contain-
ing NS4B of genotype 1b and NS5A of genotype 2a have been shown
to replicate (Han et al., 2013). Thus, we tested if NS4B and NS5A could
interact intergenotypically. Indeed FRET was observed between NS5A
from genotype 2a and NS4B from genotype 1b (mean EF 6.573.2,
po0.005), with FRET efﬁciency levels comparable to those pre-
formed using NS4B and NS5A from the same genotype as a FRET pair.
The proper and equivalent co-expression levels of the above-
mentioned proteins were assessed using western blot analysis with
primary anti-GFP and mCherry antibodies (Fig. 1B). To further
conﬁrm the physical interaction between these proteins, a mamma-
lian two-hybrid system was used. In this system one of potential
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interacting partners is fused to the DNA binding domain of a
transcription factor (GAL4) and the second to a transcription factor
activation domain (VP16). Plasmids expressing these two fusion
proteins are transfected into cells, together with a vector containing
GAL4 binding sites upstream of a minimal TATA box that controls the
expression of a luciferase reporter gene. Association of the DNA-
binding domain and the transcriptional activation domain due to an
interaction between the fusion proteins results in transcriptional
activation of the ﬁreﬂy luciferase reporter gene. The mammalian
two-hybrid interaction happens in the nucleus (fusion proteins
contain a nuclear localization signal) and thus was unlikely to occur
with the full length transmembrane NS4B. Although a recent study
provided some evidence that the N-terminal of NS4B can interact
with NS5A (Choi et al., 2013), the N-terminal domain of NS4B is
thought to translocate into the ER lumen (Lundin et al., 2006) and
thus, might be less accessible for interaction with other proteins.
The central segment of NS4B is mostly composed of transmembrane
domains, interspaced with relatively short connecting loops (Lundin
et al., 2003), thus we decided to focus on the C-terminal domain of
the protein. To this end, the C-terminal domain of NS4B (a.a. 192–
261) or NS5A from genotype 2a were cloned into both pACT (VP16
fusion) and pBind (GAL4 fusion) mammalian two-hybrid vectors.
Luciferase activity was determined 48 h post-transfection of these
vectors into Huh7 cells. The positive control consisted of MyoD and
Id, two myogenic proteins known to interact (Finkel et al., 1993).
Luciferase activity levels comparable to the positive control were
obtained when pACT-NS5A and pBIND-NS4B C-terminal domain
were coexpressed in Huh7 cells (Fig. 2A). Reverse experiments where
NS4B C-terminal domain was expressed from pACT and NS4B from
pBIND were unsuccessful (not shown). This phenomenon of speciﬁc
inserts showing an asymmetric vector preference in such assays was
previously described (Finkel et al., 1993). To rule out self-activation of
the system by the proteins themselves, pACT-NS5A and pBIND-NS4B
C-terminal domain were both co-expressed with the empty recipro-
cal plasmid. Luciferase activity in these experiments was comparable
to background levels, indicating that NS5A and the C-terminal
domain of NS4B do not activate luciferase transcription by them-
selves. The correct and comparable expression of both proteins was
assessed using western blot with VP-16 and GAL4 speciﬁc antibodies
and is shown in Fig. 2B. Taken together these results conﬁrm the
physical interaction between NS4B and NS5A.
To pinpoint the residues responsible for this interaction, point
mutations were inserted into residues in the C-terminal of NS4B. The
ability of the NS4B mutants to interact with NS5A was determined
using FRET. Our rationale in selecting the residues for mutagenesis was
based on the following hypotheses: The interaction between NS4B and
NS5A is conserved among the HCV subtypes and thus the residues to
be mutated should be well-conserved; charged residues often provide
the electrostatic surface required for protein–protein interactions
(Sheinerman et al., 2000); thus mutations were planned to replace
conserved charged residues. In general, residues belonging to the
arginine-rich RNA binding domain of NS4B or conserved residues in
their close vicinity were not replaced (Einav et al., 2008). Similarly
residues E226 shown to alter NS4B's protein stability, D256 shown to
alter polyprotein processing, and D228 shown to be part of the NS4B
NTPase motif, were not substituted as well (Blight, 2011; Einav et al.,
Fig. 1. FRET analysis of NS4B–NS5A interaction. A. Huh7 cells were co-transfected with the indicated GFP or mCherry tagged NS4B and NS5A combinations. GFP-tagged
pendrin (PDS) was used as a negative control. Acceptor photo-bleaching FRET analysis was performed 24 h post-transfection. Fluorescence of donor and acceptor was
measured as a function of time during acceptor photobleaching. Intensities within a region of interest were analyzed and are plotted in the graphs as mean FRET efﬁciency
values. Asterisks denote statistical signiﬁcance in an unpaired Student t test. **, Pr0.01; *, Pr0.05. B. Comparable expression levels of the constructs shown in panel A as
determined by Western blot using GFP and mCherry speciﬁc antibodies. Molecular mass markers are indicated on the right. Monoclonal mouse anti-β-actin antibody was
used as a loading control.
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2004). In addition to conserved charged residues two tryptophan
residues were replaced. These changes were based on the fact that a
tryptophan residue in the C-terminal domain of NS4B were previously
highlighted as a possible candidate involved in protein–protein inter-
actions (Lindström et al., 2006). Furthermore, tryptophan residues
were previously found to be statistically overrepresented in sites of
protein–protein interactions (Sillerud and Larson, 2005). Thus, muta-
genesis of conserved tryptophan residues was included in our analysis
as well. Fig. 3A shows the topology of NS4B, highlighting the cytosolic
C-terminal domain. The sequence of this region is shown above and
the location of the conserved charged residues is speciﬁed. The
indicated residues (E199;W204;H217þH222;H250 and W252) were
replaced by alanine in the context of NS4B-pmCherry for FRET
analysis. To conﬁrm that the indicated mutations did not alter the
localization of NS4B, the mutated plasmids were overexpressed in
Huh7 cells and their localization was examined using confocal micro-
scopy (Fig. 3B). All of themutants showed a localization pattern similar
to wild type NS4B (top left). Furthermore, all of the mutants showed
similar expression levels, comparable to the wild type, indicating that
these mutations did not have any signiﬁcant effect on the expression
levels of NS4B (Fig. 3C). The effect of the mutations on the NS4B–NS5A
interaction was determined by FRET analysis using acceptor photo-
bleaching. These experiments were performed in U2OS cells, a cell line
widely used for imaging experiments, due to its well-deﬁned mor-
phology. FRET efﬁciency values in these cells were similar to those
obtained in Huh7 cells (compare the wild types Fig. 1A in Huh7 with
U2OS in Fig. 3D). When coexpressed with NS5A, the NS4B mutants
E199, H217þH222, and H250 displayed FRET efﬁciency levels compar-
able to the wild type control. In contrast, mutations in two tryptophan
residues, W204 and W252, signiﬁcantly reduced FRET efﬁciency
(mean Ef¼1.370.45 and 170.4 respectively compared to 6.570.5,
po0.0001). To conﬁrm the role of W204 and W252 in the NS4B–
NS5A interaction, the effect of these mutations on their interaction in
the two-hybrid system was examined (Fig. 4). In agreement with the
FRET results, mutagenesis of W252 had a signiﬁcant effect on the
NS4B–NS5A interaction, as indicated by a 77% reduction in the
luciferase activity compared to the wild type control (po0.0001).
While W204 seemed to have a less pronounced effect in this system
compared to the FRET experiments (luciferase activity was reduced
only by 30% compared to wild type), this effect was, however, still
signiﬁcant (po0.002). To rule out the possibility of self-activation by
the mutants, each mutant was transfected with an empty pACT
plasmid. Luciferase activity compared to the background was observed
in all of these experiments. To conﬁrm that the mutations did not
affect NS4B's expression in this system, expression was assessed by
western blot with GAL4 speciﬁc antibodies (Fig. 4B). The expression of
the NS4B was not affected by the mutations in this system. Taken
together, these data suggest that these two tryptophan residues have a
role in NS4B–NS5A interaction.
Next, we sought to identify the NS5A domains participating in
this interaction. Since the various NS5A domains were linked to
different stages in the viral life cycle, identiﬁcation of a speciﬁc
domain involved could give us an insight into the functional role of
this interaction. The amphipathic helix in domain I is responsible
for the correct localization of NS5A. Thus, all of the utilized
constructs contained this domain. Two deletions were prepared,
a deletion of both DII and DIII (a.a. 1–215), and a DIII deletion
(1–341, see scheme in Fig. 5A). The effect of these deletions on the
NS4B–NS5A interaction was tested using the two-hybrid system
(Fig. 5B). Both deletion mutants were still able to interact with
NS4B showing luciferase levels comparable to the full-length
control. Interestingly, both deletion mutants showed notably
elevated luciferase activities compared to full-length NS5A. This
might be explained by the elevated expression levels of the DI
deletion mutant (Fig. 5C). To further conﬁrm these results, we
performed complementary FRET experiments with similar dele-
tion mutants. In agreement with the two-hybrid results, all the
tested combinations displayed similar FRET efﬁciencies (mean
Ef¼9.670.9 for the wild type, 870.8 for DI and 9.371.1,
Fig. 6A) for DI and DII. The deletions mutants were still able to
Fig. 2. The C terminus of NS4B interacts with NS5A in a mammalian two-hybrid system. A. Huh7 cells were transfected with the indicated plasmid combinations. In this
assay the interaction between full length NS5A and the C terminal domain (CTD) of NS4B (a.a. 192–261) was examined (see scheme). The culture media was collected 48 h
post-transfection and tested for SEAP activity as a control for transfection efﬁciency. Followed by a luciferase activity assay performed on cell lysates. Luciferase activity
results are presented as a percentage relative to the NS5A and NS4B CTD value. Values are (mean7SD) from triplicate wells. The graph is a representative result from three
independent experiments. Asterisks denote statistical signiﬁcance in an unpaired Student t test *P¼0.01; **P¼0.008. B. Comparable expression levels of the constructs are
shown in panel B as determined by Western blot using VP16 and GAL4 antibodies. Monoclonal mouse anti-β-actin antibody was used as a loading control. Molecular mass
markers are indicated on the right.
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Fig. 3. Mutations in the C terminal domain of NS4B affect its interaction with NS5A. A. Schematic representation of the predicted topology of NS4B. The C terminal domain is
highlighted. The amino acid sequence of the C terminal domain from genotype 2a is indicated (genbank accession BAB32872.1). Conserved residues are bolded and
underlined (for simplicity, labeled residues include both completely conserved residues and residues replaced with a similar amino acid). A black line above the sequence
indicates the location of the two C-terminal helices. The inserted mutations are indicated below. B. Subcellular localization of wild type and mutant NS4B constructs was
veriﬁed using confocal microscopy. Wild type NS4B-mCherry or mutants thereof were transfected into Huh7 cells grown on coverslips. Images were captured 24 h
posttransfection using a confocal microscope. Bar¼10 μM. C. Comparable expression of the NS4B mutants was conﬁrmed by Western blot. Huh7 cells were transfected with
wild type NS4B-mCherry or mutated NS4B constructs, as indicated. The cells were harvested 48 h post-transfection and the expression of the constructs was analyzed using
mCherry antibodies. Monoclonal mouse anti-actin antibody was used as a loading control. Molecular mass markers are indicated on the right. D. Acceptor photo-bleaching
FRET analysis of the NS4B C-terminal mutants. U2OS cells were co-transfected with the indicated NS4B and NS5A combinations. Acceptor photo-bleaching FRET analysis was
performed 24 h post-transfection (as described in Fig. 1). Asterisks denote statistical signiﬁcance in an unpaired Student t test. ***, Po0.0005.
N. David et al. / Virology 475 (2015) 139–149 143
localize correctly (Fig. 6B) and displayed similar expression levels
(Fig. 6C). Together this suggests that a.a 1–215 are sufﬁcient for
NS5A's interaction with NS4B. In attempt to further narrow down
the interaction domain two additional deletion mutants were
cloned into the mammalian two-hybrid vector. The ﬁrst deletion
contained the most N-terminal part of NS5A that harbors the AH
(a.a. 1–34). The second included domain I without the AH (a.a. 35–
215). The effect of both of these deletions on the NS5A–NS4B
interaction was tested in the mammalian two-hybrid system (Fig.
S3A). Transfection of the AH only construct (a.a. 1–35) with the
NS4B C-terminal domain of NS4B showed only a minor elevation
above the background. While luciferase activity levels of similarly
transfected domain I without the AH (a.a. 35–215) were similar to
background levels. Several reasons could explain this result; the
deletion might have altered the folding of the protein and dama-
ged an important motif. Or the fusion of such a short peptide to
VP16 and GAL4 might have masked a region important for the
interaction. The correct and comparable expression levels of the
plasmids were determined using western blot (Fig. S3B).
To assess the possible functional consequences of this interaction,
we tested the ability of all the aforementioned mutants to replicate in
the context of the J6/JFH luciferase reporter virus ((Tscherne et al.,
2006), Fig. 7A). While mutations in E199A and H250A effect viral
replication only moderately, the mutations W204A, H217AþH222A
and W252 completely abolished viral replication. Similar results were
obtained for these residues in previous studies (Blight, 2011; Jones et
al., 2009; Paul et al., 2011). These data demonstrate the important role
of these residues in the formation and function of the viral replication
complex. NS4B was found, among other proteins, to be essential for
the hyperphosphorylation of NS5A (Koch and Bartenschlager, 1999;
Neddermann et al., 1999). Deletions in the C-terminal of NS4B
abolished NS5A hyperphosphorylation (Koch and Bartenschlager,
1999). To examine if the point mutations disturbing the NS4B–NS5A
interaction, affect NS5A phosphorylation, a vaccinia virus/T7 polymer-
ase expression system was used (Sutter et al., 1995). Huh7 cells were
infected with T7 polymerase expressing vaccinia virus, followed by
Fig. 4. C-terminal mutations within NS4B affect its interaction with NS5A in the two-
hybrid system. A. Huh7 cells were transfected with the indicated plasmid combina-
tions. The culture media was collected 48 h post-transfection and tested for SEAP
activity as a control for transfection efﬁciency, followed by a luciferase activity assay
performed on cell lysates. Luciferase activity results are presented as a percentage
relative to the NS5A and NS4B CTD value. Values are (mean7SD) from triplicate wells.
The graph represents three independent experiments. Asterisks denote statistical
signiﬁcance in an unpaired Student t test ***Po0.0005; **Po0.005. B. Expression levels
of the mutant NS4B constructs are shown in panel A, as determined by Western blot
using GAL4 antibodies. Monoclonal mouse anti-β-actin antibody was used as a loading
control. Molecular mass markers are indicated on the right.
Fig. 5. NS5A a.a 1–215 are sufﬁcient to mediate its interaction with NS4B. A. Schematic
representation of the three NS5A constructs used. The N-terminal amphipathic helix
(AH) is labeled in gray; Domain I and II are abbreviated as DI and DII respectively. Amino
acid numbers are indicated above. B. The interaction between NS5A domains and NS4B
CTD was determined using the two-hybrid system. Full length NS5A, NS5A a.a 1–215 or
NS5A a.a 1–341 from genotype 2a were cloned into the appropriate two hybrid vectors.
NS4B CTD and NS5A constructs were transfected into Huh7 cells as indicated. The
culture media was collected 48 h post-transfection and tested for SEAP activity as a
control for transfection efﬁciency. Followed by a luciferase activity assay preformed on
the cell lysates. Luciferase activity results are presented as a percentage relative to the
full length NS5A and NS4B CTD value. Values are (mean7SD) from triplicate wells. The
graph is a representative result from three independent experiments. Values are
(mean7SD) from triplicate wells. C. Expression levels of the NS5A deletion mutants
shown in panel A and B. Expression levels were determined in Huh7 cells using western
blot with VP16 antibodies. Monoclonal mouse anti- β-actin antibody was used as a
loading control. Molecular mass markers are indicated on the right.
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transfection with the replication deﬁcient genomes, expressed from a
mutated JFH-1 subgenomic replicon DNA (pSGR-JFH1). The cells were
analyzed using western blot with an NS5A speciﬁc antibody 20 h post-
transfection. Typical bands at 56 and 58 kDa representing basal and
hyperphosphorylated forms of NS5A, respectively, were observed for
the wild type replicon and for the W204A and the H217AþH222A
mutants (Fig. 7B). In contrast, the hyperphosphorylated form of NS5A
was completely abolished in the replicon carrying the W252A muta-
tion. These ﬁndings are in agreement with results of the two-hybrid
interaction assay, where a signiﬁcant yet moderate effect of W204A on
the NS4B–NS5A interaction was observed. On the other hand, W252A
had a pronounced effect on the NS4B–NS5A interaction in both FRET
and mammalian two-hybrid assays, suggesting that the W204 NS4B
mutation might still retain some of its NS5A binding capability while
W252A mutation abolishes this interaction. Our results support the
notion that the NS4B–NS5A interaction is necessary for viral replica-
tion and may be involved in mediating the NS5A hyperphosph-
orylation.
Discussion
NS4B and NS5A are essential for HCV replication and assembly.
Several lines of evidence indicate that these two proteins interact
Fig. 6. FRET analysis of the NS5A deletion mutants. A. U2OS cells were co-transfected with the indicated NS4B and NS5A combinations. Acceptor photo-bleaching FRET
analysis was performed 24 h post-transfection (as described in Fig. 1). B. Subcellular localization of the NS5A deletion mutants. U2OS cells plated on coverslips were
transfected with the indicated NS5A expressing constructs. Subcellular localization was determined using confocal microscopy 24 h post-transfection. C. Comparable
expression of the NS5A deletion mutants was determined using western blot with anti-GFP antibodies. Monoclonal mouse anti-β-actin antibody was used as a loading
control. Molecular mass markers are indicated on the right.
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functionally and genetically. However, although previously detected
(Aligo et al., 2009; Dimitrova et al., 2003; Gao et al., 2004), their
physical interactionwas never fully characterized. Here, we conﬁrmed
this interaction using two independent methods FRET of ectopically
expressed proteins; and the mammalian two-hybrid system.
Efforts to perform FRET experiments with a full-length replicon
containing a GFP insertion within NS5A and ectopically expressed
NS4B were not successful. This may be attributed to the inacces-
sibility of the GFP under these conditions. Speciﬁc conserved
residues in the C-terminal domain of NS4B, W204 and W252
were found to have a central role in mediating this interaction.
Mutations in these residues abolished viral replication.
HCV replicates in highly ordered multi-subunit membrane
associated RCs (Gao et al., 2004). In addition to the previously
characterized complex heterotypic interactions that occur within
RCs, a growing list of viral proteins including NS4B, NS5A and most
recently NS4A were reported to function as dimers or oligomers
(Dimitrova et al., 2003; Gouttenoire et al., 2010; Kohlway et al.,
2013; Love et al., 2009; Tellinghuisen et al., 2005; Yu et al., 2006).
Interestingly the W204A mutant that affects the NS4B–NS5A
interaction was previously shown to impair NS4B heterotypic
oligomerization as well (Paul et al., 2011). Similar results regarding
W204A were obtained in our hands, however, the effect of W252A
was inconclusive due to high variability (FRET efﬁciency did not
signiﬁcantly differ from the wild type, not shown). Conﬁrmation
that these proteins bind the same domain deserves further studies.
If proven, this possibility should be taken under consideration
when a model for HCV RC assembly is formulated.
NS5A apparently associates with the RC via interaction with
other NS proteins. This was shown using ﬂuorescence recovery after
photobleaching (FRAP) analysis by demonstrating its increased
mobility in the absence of the other NS proteins (Jones et al.,
2007). FRAP analysis of NS5A-GFP expressed as a part of the HCV
polyprotein was used to determine the possible role of NS4B in
mediating the mobility of NS5A. Deletion of NS4B from this con-
struct signiﬁcantly increased the mobility of NS5A (Jones et al.,
2009). NS5A-GFP expressed from a polyprotein in which NS4B was
carrying the W252A mutation displayed a similar mobility to the
NS4B deletion supporting the notion that NS4B has a role in the
association of NS5A with the RC. In agreement with our results
Jones et al. showed that W252A abolishes viral replication, prevents
NS4B induced foci formation and NS5A hyperphosphorylation
(Jones et al., 2009).
Efforts to isolate reversions from replicons carrying either W204A
orW252Amutations were unsuccessful, both in our hands and others
(Lindström et al., 2006; Paul et al., 2011) demonstrating the impor-
tance of these residues. However, replication of a W252A mutant
replicon could be partially rescued by a wild type replicon or a
replicon defective in NS5A (Jones et al., 2009). Suggesting that NS4B
could interact with NS5A supplied in trans. NS4B is a membrane
protein, with relatively slow mobility and thus does not readily
transfer between foci. This fact, together with the low efﬁciency of
trans-complementation, suggests that complementation probably
occurs within a single focus (Gretton et al., 2005; Jones et al., 2009).
The function of NS5A phosphorylation is still not understood,
although mutations that lower the amount of the hyperpho-
sphorylated form of NS5A are believed to stimulate viral replica-
tion (Appel et al., 2005b; Blight et al., 2000; Katze et al., 2000;
Tanji et al., 1995b). Nevertheless, minimal levels of hyperpho-
sphorylated NS5A seem to be essential for viral replication, since
viral replication is inhibited upon its complete loss (Appel et al.,
2005a; Fridell et al., 2011). In agreement with this notion, Jones
et al. found a direct correlation among the ability of NS4B to form
foci, the increased mobility of NS5A and its phosphorylation state
(Jones et al., 2009). In our study, the hyperphosphorylated state of
NS5A expressed from a replicon DNA with a W204A mutation
resembled the wild type, while only basal-phosphorylated NS5A
was present in a W252A containing replicon.
NS4B was shown to be essential for NS5A phosphorylation
(Koch and Bartenschlager, 1999; Neddermann et al., 1999). To
produce and maintain its hyperphosphorylated state, NS5A might
need to be in an appropriate conformation, recruit host kinases or
other assisting factors and to protect its phosphorylated sites from
phosphatases (Koch and Bartenschlager, 1999; Neddermann et al.,
1999). These roles may be provided by its interaction with NS4B.
Although both of our mutations inhibited viral replication and
affected the NS4B–NS5A interaction, some prominent differences
exist which may explain the ability of the W204A mutation to
support hyperphsophorylation of NS5A. While both of the muta-
tions reduced FRET efﬁciency by comparable levels, signiﬁcant
differences between the mutations were observed in the two-
hybrid assay, where W204A had only a moderate effect on the
NS4B–NS5A binding. In our hands, viral replication was abolished
to the same extent with both mutants, while Paul et al. reported
that W204A was able to support low levels of replication (Paul
et al., 2011). These data suggest that W204A retains some of its
NS5A binding activity and this residual activity is sufﬁcient to
Fig. 7. Mutations in the C-terminus of NS4B affect HCV replication and NS5A
phosphorylation. A. Huh7.5 cells were transfected with in vitro transcribed RNA
from a monocistronic reporter virus (J6/JFH(50C19Rluc2AUbi)) encoding a full-
length infectious J6/JFH genome with the Renilla luciferase reporter. Luciferase
activity was determined in cell lysates at 6, 24, 48, and 72 h posttransfection.
Luciferase activity in relative light units (RLU) is plotted for each time point. The
data was normalized to the 6 h values that reﬂect transfection efﬁciency and to
background luciferase levels determined using a replicon with a mutation in the
viral RNA dependent RNA polymerase. Results represent mean values7SEM from
two independent experiments performed in triplicates. B. Expression of pSGR-JFH-
1 with the NS4B C terminal mutations using the vaccinia virus infection/transfec-
tion system. Huh7 cells were infected with a T7 polymerase expressing modiﬁed
vaccinia virus, followed by transfection with the indicated pSGR DNA. To monitor
the NS5A phosphorylation status, the cells were lysed 20 h post-transfection and
analyzed by western blot using the 9E10 anti-NS5A monoclonal antibody. Mono-
clonal mouse anti-β-actin antibody was used as a loading control. Shown is a
representative blot from 2 independent experiments. Asterisk indicates the
hyperphosphorylated form of NS5A. Molecular mass markers are indicated on
the right.
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modulate NS5A hyperphosphorylation. In contrast, W252A seems
to be a major mediator of this interaction; its mutagenesis causes
detrimental effects on the ability of the virus to replicate.
Interestingly, a double H217AþH222A mutation did not affect
NS5A phosphorylation. This mutation also did not affect the NS4B–
NS5A interaction, but it was still unable to support viral RNA
replication. The fact that the H222A mutation was previously
shown to inhibit the NS4B–NS4B heterotypic interaction (Paul et
al., 2011) might account for the inability of this mutant to support
viral replication. Nevertheless, this result further highlights the
functional differences between these interactions.
Our results point to domain I of NS5A as the area responsible for
the interaction. Interestingly, resistance mutants to several of the
most advanced direct acting antivirals targeting NS5A map to this
region (for a recent review see (Lim and Gallay, 2014)). Our results
might suggest that modulation of the NS4B–NS5A interaction could
be added to the list of potential NS5A direct acting antivirals targets.
Experimental procedures
Cell culture and transfections
Huh7, Huh7.5 and Huh7 cells harboring a subgenomic 1b
replicon with an in frame hemagglutinin (HA) tag insertion in
NS5A (Bart-HA, (Sklan et al., 2007)) were propagated in Dulbecco's
Modiﬁed Eagle's Medium (DMEM) supplemented with 10% (v/v)
fetal calf serum, 1% (v/v) penicillin/streptomycin and 1% (v/v) of
MEM Non-Essential Amino Acids (Biological Industries, Bet-Hae-
mek, Israel). The Bart-HA cells were grown in the presence of
0.7 mg/ml G418 (Calbiochem, San Diego, CA). U2OS cells were
propagated in DMEM supplemented with 10% FBS and 1% peni-
cillin/streptomycin. Lipofectamine 2000 (Invitrogen, Carlsbad, CA)
or polyethyleneimine (Polysciences, Warrington, PA) were used for
plasmid DNA transfections of subconﬂuent Huh7 and U2OS cells.
Plasmids
The plasmid expressing green ﬂuorescent protein (GFP) or
mCherry fusions with NS4B from HCV genotype 2a were created by
amplifying the NS4B coding sequence from pFL-J6/JFH DNA and
subcloning the obtained insert into pEGFP-N1 and pmCherry-N1
(Clontech, Palo Alto, CA). The pmCherry-N1 plasmid expressing
NS4B from genotype 1b fused to mCherry was generated by amplify-
ing NS4B from Bart79I, a genotype 1b subgenomic replicon (Einav et
al., 2004), and cloning the obtained insert into pmCherry-N1. The
plasmids expressing NS5A(2a)-GFP, NS5A(1b)-mCherry and pEF-NS4B
(1b)-GFP were previously described (Einav et al., 2004; Nevo-Yassaf et
al., 2012). The plasmids expressing the different NS5A domains fused
to GFP were generated by amplifying NS5A a.a. 1–247 or NS5A a.a. 1–
352 from the NS5A(2a)-GFP vector to generate the insert that was
ligated into the HindIII/AgeII restriction sites of pEGFP-N1. GFP tagged
pendrin (GFP-PDS) was previously described (Shepshelovich et al.,
2005). To generate the pACT and pBIND plasmids for the mammalian
two hybrid system, NS5A of its fragments were ampliﬁed from NS5A-
GFP(2a) and subcloned into the XbaI/NotI sites of pACT or pBIND.
Similarly the C-terminal domain of NS4B (a.a. 192–261) was ampliﬁed
from NS4B-mCherry (2a), and the PCR products were digested with
XbaI and NotI and ligated into pACT or pBIND. pSGR-JFH1 was kindly
provided by T. Wakita (National Institutes of Infectious Diseases, Japan)
has been previously described (Kato et al., 2003).Mutagenesis was
performed using either tail-to-tail PCR (Hemsley et al., 1989) or the
QuickChange II site-directed mutagenesis kit (Strategene, La Jolla, CA).
Western blot analysis
Proteins were extracted using cell lysis buffer (300 mM NaCl,
100 mM Tris–HCl pH 8, 0.2 mM EDTA, 10% Glycerol) supplemented
with a protease inhibitor cocktail (Sigma). The cell lysates were
separated using sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) and transferred to a nitrocellulose mem-
brane. Membranes were then blocked for 1 h in blocking solution
[Phosphate buffer saline (PBS) containing 5% non-fat milk (Sigma,
Israel)] followed by incubation with the appropriate primary
antibody. Primary antibodies used were mouse monoclonal anti-
GAL4 and VP-16 antibodies (Santa Cruz biotechnology, Dallas, TX),
rabbit polyclonal anti-RFP antibody (MBL, Woburn, MA) and a
rabbit anti-GFP polyclonal antibody (Abcam, Cambridge, MA).
Monoclonal mouse antibodies against β actin and Actin were from
Sigma and Santa Cruz, respectively. The mouse monoclonal 9E10
antibody against NS5A, was kindly provided by Charles M. Rice
(Rockfeller University). The blots were then incubated with the
corresponding IR-Dye conjugated secondary antibodies (Li-cor,
Lincoln, NE). Proteins were visualized using a LI-COR infrared
imager (Odyssey).
In-vitro transcription and electroporation of HCV RNAs
In vitro transcripts of J6/JFH (50C19Rluc2AUbi) were prepared as
described Lindenbach et al., 2005; Tscherne et al., 2006. Brieﬂy,
plasmid DNA was linearized using XbaI. The linearized DNA
template was puriﬁed using phenol:chloroform extraction and
ethanol precipitation. The linearized template was transcribed
with T7 RNA polymerase using a MEGAscript™ T7 kit (Ambion,
Austin, TX). Reaction mixtures were incubated for 3 h at 37 1C and
then subjected to DNase treatment for an additional15 min at
37 1C. The integrity of the RNA was analyzed by non-denaturing
agarose gel electrophoresis and the yield was determined spectro-
photometrically. For the electroporation, Huh7.5 cells were grown
to 60–80% conﬂuency, trypsinized and washed twice in cold
RNAse-free PBS (BioWhitaker, Walkersville, MD). Cells were resus-
pended in cold PBS at a concentration of 1.5107 cells/ml; 0.4 ml
of the cell suspension was mixed with 5 mg in vitro-transcribed
RNA. The mixture was dispensed into a 2-mm gap width cuvette
(BTX, San Diego, CA) and electroporation was performed using a
BTX model 830 electroporator (820 V, 599-ms pulses given at
220-ms intervals). Cells were left to recover for 15 min at room
temperature and then mixed with 10 ml of pre-warmed (37 1C)
growth medium. Cells were seeded in six-well plates, luciferase
levels were determined 6, 24, 48 and 72 h post-electroporation.
For the luciferase assay electroporated cells were washed twice
with PBS and lysed with reporter lysis buffer (Promega, Madison,
WI) followed by 15 min of shaking at room temperature, luciferase
activity was determined using Renilla luciferase substrate (Cole-
trazine, Calbiochem) and a Mithras LB 940 multimode microplate
reader (Berthold technologies, Bad Wildbad Germany)
Mammalian two-hybrid experiments
NS4B and NS5A were subcloned into pACT and pBIND plasmids
(CheckMate; Promega). The appropriate plasmids (500 ng of each)
were transfected together with the reporter plasmid pG5luc into
Huh7 cells plated in 24-well plates at a conﬂuence of 60–80%. A
plasmid expressing secreted alkaline phosphatase (SEAP, 50 ng)
was added to each transfection reaction as a transfection efﬁciency
control. Media from the cells was removed 48 h post-transfection
and analyzed for SEAP activity using the Phospha-Light System
(Applied biosystems, Foster city, CA). The cells were lysed with
luciferase reporter lysis buffer (Promega) and luciferase activity
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was determined using a Mithras LB 940 multimode microplate
reader (Berthold technologies).
Infection and transfection
Huh7 cells were infected with modiﬁed vaccinia Ankara virus
(MVA) expressing the T7 RNA polymerase (Sutter et al., 1995).
Following an incubation of 1 h at 37 1C, the cells were washed twice
with Optimem (Invitrogen) and wild type or mutant pSGR-JFH1
DNA was transfected with Lipofectamine 2000 (Invitrogen) accord-
ing to the manufacturer's instructions. The cells were supplemented
with growth media 4 h post-transfection and harvested for Western
blot analysis with mouse monoclonal 9E10 antibody against NS5A
20 h post-transfection.
FRET analysis using acceptor photobleaching
Acceptor photobleaching was essentially carried out as
described (Yaffe et al., 2012). Brieﬂy, Huh7 or U2OS cells were
grown on coverslips and transfected with NS4B and NS5A fused to
mCherry (acceptor) or GFP (donor) using polyethyleneimine. GFP-
PDS was used as a negative control. The cells were ﬁxed 24 h post-
transfection. A region of interest containing the mCherry acceptor
was repeatedly photobleached in 4 to 6 cycles using 564 nm HeNe
laser. Changes in the ﬂuorescence intensity of the GFP donor and
photobleached acceptor were measured using 488 nm Ar and
564 nm HeNe lasers. FRET efﬁciencies (EF) from at least 10




where Dpost is the ﬂuorescence intensity of the donor after
acceptor photobleaching and Dpre is the ﬂuorescence intensity of
the donor before acceptor photobleaching. All calculated FRET
efﬁciency values were normalized to levels of photobleached
acceptor calculated as the percent of reduction in the initial
ﬂuorescent intensity (prior to photobleaching).
Supplementary methods
Immunoﬂuorescence microscopy
Bart-HA cells were cultured on coverslips, ﬁxed with 2% form-
aldyhyde, permeabilized with 0.2 % saponin and blocked with 3 %
fetal bovine serum (FBS) followed by immunolabeling with an
monoclonal primary antibody against NS4B (Abcam) and an anti-
HA rabbit polyclonal antibody (Santa Cruz Biotechnology). The
secondary antibodies were Alexa 488 goat anti-mouse antibody
(Invitrogen) and Cy3 goat anti-rabbit (Jackson ImmunoResearch,
West Grove, PA). Images were acquired using a Zeiss Pascal con-
focal laser scanning microscope.
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